BridgeMD
Prevention study for Atrial Fibrillation (AF)
Official title Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy
ClinicalTrials.gov ID: NCT06728826
What this study is testing
- What it's testing
- PRINCE-CH is a multicentre, randomized controlled trial which evaluates the effectiveness and safety of posterior pericardiotomy in preventing POAF after cardiac surgery in Chinese population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients older than or equal to 18 years of age
- Requiring surgical intervention on proximal aorta, cardiac valves, and/or coronary arteries
- Able to provide informed consent
You likely can't join if
- History of atrial fibrillation or flutter
- Reoperations/minimally invasive cardiac surgery/emergent presentation
- Need for hypothermic circulatory arrest
- Disease of the left pleura or previous left thoracotomy
- Chest deformity
- Unlikely to participate in follow-up assessments
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.